Reduced food intake from GLP-1 therapy can compound nutrient depletion that breastfeeding naturally causes
Efficacy and safety of taspoglutide monotherapy in drug-naive type 2 diabetic patients after 24 weeks of treatment: results of a randomized, double-blind, placebo-controlled phase 3 study (T-emerge 1)
Cheng CK, Luo JY, Lau CW, Cho WC, Ng CF, Ma RCW, Tian XY, Huang Y
GIP and GLP1 reduce appetite by signalling through their receptors that are expressed in multiple regions of the central nervous system
Navigate to the pharmacy benefits section and look for the drug list or formulary
GLP-1R agonists improve the metabolic status of diabetic patients through a variety of mechanisms, which provides a new strategy and direction for the treatment of T2DM